Apple Tree Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 12
Professionals
  • Investments
  • 56
  • Portfolio
  • 10
  • Exits
  • 27
Exits

Apple Tree Partners General Information

Description

Founded in 1999, Apple Tree Partners is a life sciences venture capital firm that invests in its portfolio companies from seed stage through IPO and beyond. The firm has offices in New York, Cambridge, MA, and London, and focuses its investments in the US, UK and Europe.

Contact Information

Year Founded
1999
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 230 Park Avenue
  • Suite 2800
  • New York, NY 10169
  • United States
+1 (212) 000-0000

Apple Tree Partners Investments (56)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Chinook Therapeutics 18-Aug-2020 Early Stage VC 00000 Drug Discovery Pre-Clinical Trials 000000 0000 00.0
0000 000000 000000 16-Jun-2020 00000 00000 0000 Drug Discovery Startup 0000 00000000 00
0000 000000000000 18-Nov-2019 00000 00000 000.00 Therapeutic Devices Clinical Trials - Phase 2 00000 00000000
0000000 0000000000 22-Aug-2019 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000 0000 00.0
000000000 000 05-Aug-2019 00000 00000 0000 Biotechnology Startup 0000 00000000 00
00000 000000000000 12-Dec-2018 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 0000000
00000 000000000000 23-Oct-2018 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 000000 0000 00.0
00000 000000000000 25-Jun-2018 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 0000000
Corvidia Therapeutics 25-Apr-2018 Early Stage VC 0000 Biotechnology Generating Revenue 00000 0000000
Braeburn 19-Jan-2018 Mezzanine 00000 Biotechnology Generating Revenue 00000 00000000
You’re viewing 10 of 56 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apple Tree Partners Exits (27)

Company Name Exit Date Exit Type Exit Size
Akero Therapeutics 09-Jul-2020 Public Investment 2nd Offering 00000
00000000 000000000 11-Jun-2020 000000000000000000 00.00
000000 0000000 24-Jan-2020 000000000000000000 00000
00000 000000000000 20-Jun-2019 000 0000
00000 000000000000 19-Jun-2019 000 00000
000 0000000 01-Jan-2019 000 00 00000000
0000000000 02-Nov-2018 000000000000000000 00.00
0000000 16-Mar-2018 000000000 00000000
Narus Health 05-Dec-2017 Buyout/LBO
QualDerm Partners 05-Dec-2017 Secondary Transaction - Private
You’re viewing 10 of 27 exits. Get the full list »

Apple Tree Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Apple Tree Partners Team (49)

Name Title Deals Funds Boards Office
Seth Harrison MD Founder & Managing Partner 00 0 0 New York, NY
Michael Ehlers Ph.D Chief Scientific Officer & Venture Partner 0 Boston, MA
Andrew Bayliffe Ph.D Venture Partner London, United Kingdom
Jim Faulkner Ph.D Venture Partner London, United Kingdom
Joseph Yanchik JD Venture Partner Boston, MA
You’re viewing 5 of 49 team members. Get the full list »

Apple Tree Partners Co-Investors (40)

Name With Exits Lead Partner Series Industry
Cormorant Asset Management 3 0 0 Series chart Industry bar
Janus Henderson Investors 0 0 Series chart Industry bar
Versant Venture Management 0 0 0 Series chart Industry bar
Redmile Group 0 0 Series chart Industry bar
Northleaf Capital Partners 0 0 Series chart Industry bar
You’re viewing 5 of 40 co-investors. Get the full list »